血液恶性病和急性呼吸系统衰竭的住院患者的流行病学和结果
Anoosha Ponnapalli1, Aditya Sharma2, Mariam Fatima2
1Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA.
Hematology/oncology and stem cell therapy
|March 6, 2026
概括
急性呼吸衰竭 (ARF) 影响了超过12%的血液恶性瘤住院患者,显著增加死亡率和医疗保健成本. 侵入性机械通风 (IMV) 进一步增加了这些风险,强调了针对性干预的必要性.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 流行病学 流行病学
背景情况:
- 患有血液性恶性瘤的患者面临急性呼吸衰竭 (ARF) 的风险增加.
- 在这个患者群体中,ARF是重症监护室入院和死亡率的主要驱动因素.
- 了解ARF的影响对于改善血液恶性瘤患者的护理至关重要.
研究的目的:
- 在患有血液性恶性瘤的住院患者中描述ARF的流行病学.
- 分析与ARF相关的临床结果和医疗保健利用情况.
- 确定影响死亡率和资源使用的因素.
主要方法:
- 使用2016-2019年全国住院患者样本进行的回顾性队列研究.
- 使用ICD-10-CM代码识别患有血液性恶性瘤的成人住院病例.
- 基于ARF存在和侵入性机械通风 (IMV) 使用的分层.
主要成果:
- 在240万例血液性恶性瘤住院患者中,ARF发生在12.5%的患者中.
- 接受ARF治疗的患者年龄较大,并发病率较高,败血症和急性损伤 (AKI) 的发生率较高.
- 住院死亡率为ARF的22.7%,而没有ARF的2.2%;IMV使用 (27.7%的ARF病例) 的死亡率为49.7%,住院时间更长,成本更高.
- 在IMV患者中死亡的独立预测因素包括老年,AKI和中性质减退.
结论:
- ARF影响超过10%的住院血液恶性瘤患者,与增加的死亡率和医疗保健利用率有关.
- 虽然结果有所改善,但ARF,特别是IMV,仍然是一个重大挑战.
- 早期风险分层和有针对性的干预措施对于这种高风险人群至关重要.
相关概念视频
Acute Respiratory Failure-II
1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Acute Respiratory Failure-V
564
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
564
Acute Respiratory Failure-I
1.3K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K
Pneumonia IV: Management
976
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
976
Acute Respiratory Failure-III
1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Acute Respiratory Failure-IV
638
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
638

